Us Bancorp \De\ Zai Lab LTD Transaction History

Us Bancorp \De\

$82.9 Billion
Q3 2025

A detailed history of Us Bancorp \De\ transactions in Zai Lab LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 24,762 shares of ZLAB stock, worth $538,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,762

Previous 24,438 1.33%

Holding current value

$538,573

Previous $854,000 1.76%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$28.4 - $40.51 $9,201 - $13,125	324 Added 1.33%	24,762 $839,000
Q2 2025 Jul 23, 2025	BUY	$24.32 - $43.03 $147,695 - $261,321	6,073 Added 33.07%	24,438 $854,000
Q1 2025 May 08, 2025	BUY	$24.29 - $38.35 $303,625 - $479,375	12,500 Added 213.13%	18,365 $663,000
Q4 2024 Feb 05, 2025	BUY	$24.61 - $33.18 $136,191 - $183,618	5,534 Added 1671.9%	5,865 $153,000
Q3 2024 Oct 28, 2024	SELL	$16.25 - $24.14 $715 - $1,062	-44 Reduced 11.73%	331 $7,000

Q2 2024 Aug 06, 2024	BUY	$13.72 - $21.55 $5,145 - $8,081	375 New	375 $6,000
Q4 2023 Feb 09, 2024	BUY	$22.97 - $30.58 $4,157 - $5,534	181 Added 119.87%	332 $9,000
Q3 2023 Nov 03, 2023	SELL	$22.72 - $31.49 $3,158 - $4,377	-139 Reduced 47.93%	151 $3,000
Q2 2023 Aug 09, 2023	BUY	$25.3 - $39.67 $7,337 - $11,504	290 New	290 $8,000
Q3 2022 Oct 27, 2022	BUY	$34.2 - $51.69 $342 - $516	10 New	10 $0
Q2 2022 Aug 01, 2022	SELL	$23.14 - $49.68 $5,322 - $11,426	-230 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$27.77 - $64.4 $89,697 - $208,012	-3,230 Reduced 93.35%	230 $10,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $67,417 - $129,197	1,228 Added 55.02%	3,460 $217,000
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $5,250 - $8,918	50 Added 2.29%	2,232 $235,000
Q2 2021 Aug 05, 2021	SELL	$125.11 - $180.0 $2,001 - $2,880	-16 Reduced 0.73%	2,182 $386,000
Q1 2021 Apr 28, 2021	BUY	$126.27 - $191.71 $20,329 - $30,865	161 Added 7.9%	2,198 $294,000
Q4 2020 Feb 04, 2021	BUY	$81.94 - $135.34 $26,466 - $43,714	323 Added 18.84%	2,037 $276,000
Q3 2020 Nov 10, 2020	BUY	$73.3 - $89.48 $66,336 - $80,979	905 Added 111.87%	1,714 $142,000
Q2 2020 Aug 07, 2020	BUY	$48.82 - $82.53 $21,383 - $36,148	438 Added 118.06%	809 $67,000
Q1 2020 May 13, 2020	BUY	$39.1 - $62.9 $5,904 - $9,497	151 Added 68.64%	371 $19,000
Q4 2019 Feb 04, 2020	BUY	$29.79 - $43.06 $2,442 - $3,530	82 Added 59.42%	220 $9,000
Q4 2018 Feb 13, 2019	BUY	$14.95 - $24.72 $2,063 - $3,411	138 New	138 $3,000

Others Institutions Holding ZLAB

# of Institutions

154

Shares Held

32.7M

Call Options Held

168K

Put Options Held

222K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.13B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account